CD5 and adult T-cell leukemia/lymphoma: We found CD5 status to be associated with overall (Figure 4A) and progression free survival (Figure 4B) in TFH TCL (n = 49, p =0.04) and ATLL (n = 9, p = 0.04), where the CD5-positivity was associated with worse prognosis.